The Journal of Immunology, Vol 147, Issue 10 3434-3440, Copyright © 1991 by American Association of Immunologists

ARTICLES

Physical associations between CD45 and CD4 or CD8 occur as late activation events in antigen receptor-stimulated human T cells

RS Mittler, BM Rankin and PA Kiener
Bristol Myers Squibb Pharmaceutical Research Institute, Department of Immunology, Wallingford, CT 06492-7660.

Activation of human PBL T cells with solid phase anti-CD3 mAb or during the course of an MLR response gives rise to the association of CD4 or CD8 molecules with the protein tyrosine phosphatase, CD45, on the cell surface. This paired association of cell-surface molecules occurs late in the activation cycle and appears to be dependent upon Ti-CD3- mediated signaling because mitogen-driven activation does not induce formation of the complex. Maximal association occurred 72 to 96 h after exposure to anti-CD3 mAb on both CD4+ and CD8+ T cells. In contrast, association between CD8 and CD45 during an MLR response did not occur until day 6 of a MLR whereas CD4-CD45 association was detected by 72 h of culture. The kinetics of association between CD4 or CD8 and CD45 was measured by fluorescence resonance energy transfer and confirmed by immunoprecipitation of dithiobis succinimidylpropionate or disuccinimidyl suberate cross-linked 125I-labeled resting or activated T cells. The molecules that co-precipitated with either CD4 or CD8 and had an apparent kDa of 180 to 205 could be immunodepleted with anti- CD45 mAb. Furthermore, CD4 or CD8 immunoprecipitates from 96-h activated T cells contained significant levels of protein tyrosine phosphatase activity whereas corresponding immunoprecipitates from resting or recently activated T cells showed little protein tyrosine phosphatase activity. This association may allow CD45 to engage and dephosphorylate lck or another CD4- or CD8-associated substrate in order to reset the receptor complex to receive a new set of stimuli. Our observations suggest that synergistic signaling provided as a consequence of CD4 or CD8 association with the TCR after antigenic stimulation may develop on a different temporal scale than that observed after soluble anti-CD4+ anti-CD3 heteroconjugate antibody cross-linking.

This article has been cited by other articles:

				T. Yamada, D. Zhu, A. Saxon, and K. Zhang CD45 Controls Interleukin-4-mediated IgE Class Switch Recombination in Human B Cells through Its Function as a Janus Kinase Phosphatase J. Biol. Chem., August 2, 2002; 277(32): 28830 - 28835. [Abstract] [Full Text] [PDF]

				N. Blank, M. Kriegel, T. Hieronymus, T. Geiler, S. Winkler, J. R. Kalden, and H.-M. Lorenz CD45 Tyrosine Phosphatase Controls Common {{gamma}}-Chain Cytokine-Mediated STAT and Extracellular Signal-Related Kinase Phosphorylation in Activated Human Lymphoblasts: Inhibition of Proliferation Without Induction of Apoptosis J. Immunol., May 15, 2001; 166(10): 6034 - 6040. [Abstract] [Full Text] [PDF]

				S. Gratton, M. Julius, and R.-P. Sekaly lck-Independent Inhibition of T Cell Antigen Response by the HIV gp120 J. Immunol., October 1, 1998; 161(7): 3551 - 3556. [Abstract] [Full Text] [PDF]

				B. M. Kessler, P. Bassanini, J.-C. Cerottini, and I. F. Luescher Effects of Epitope Modification on T Cell Receptor-Ligand Binding and Antigen Recognition by Seven H-2Kd-restricted Cytotoxic T Lymphocyte Clones Specific for a Photoreactive Peptide Derivative J. Exp. Med., February 17, 1997; 185(4): 629 - 640. [Abstract] [Full Text] [PDF]

				T. J. Brown, W. W. Shuford, W.-C. Wang, S. G. Nadler, T. S. Bailey, H. Marquardt, and R. S. Mittler Characterization of a CD43/Leukosialin-mediated Pathway for Inducing Apoptosis in Human T-Lymphoblastoid Cells J. Biol. Chem., November 1, 1996; 271(44): 27686 - 27695. [Abstract] [Full Text] [PDF]

				T. M. Friedman, A. P. Reddy, R. Wassell, B. A. Jameson, and R. Korngold Identification of a Human CD4-CDR3-like Surface Involved in CD4+ T Cell Function J. Biol. Chem., September 13, 1996; 271(37): 22635 - 22640. [Abstract] [Full Text] [PDF]

				D. H. W. Ng, J. D. Watts, R. Aebersold, and P. Johnson Demonstration of a Direct Interaction between p56[IMAGE] and the Cytoplasmic Domain of CD45 in Vitro J. Biol. Chem., January 19, 1996; 271(3): 1295 - 1300. [Abstract] [Full Text] [PDF]

				K. Kitamura, A. Maiti, D. H. W. Ng, P. Johnson, A. L. Maizel, and A. Takeda Characterization of the Interaction between CD45 and CD45-AP J. Biol. Chem., September 8, 1995; 270(36): 21151 - 21157. [Abstract] [Full Text] [PDF]

				A. McShea, T. Samuel, J.-T. Eppel, D. A. Galloway, and J. O. Funk Identification of CIP-1-associated Regulator of Cyclin B (CARB), a Novel p21-binding Protein Acting in the G2 Phase of the Cell Cycle J. Biol. Chem., July 21, 2000; 275(30): 23181 - 23186. [Abstract] [Full Text] [PDF]

				S. Dornan, Z. Sebestyen, J. Gamble, P. Nagy, A. Bodnar, L. Alldridge, S. Doe, N. Holmes, L. K. Goff, P. Beverley, et al. Differential Association of CD45 Isoforms with CD4 and CD8 Regulates the Actions of Specific Pools of p56lck Tyrosine Kinase in T Cell Antigen Receptor Signal Transduction J. Biol. Chem., January 11, 2002; 277(3): 1912 - 1918. [Abstract] [Full Text] [PDF]